Bottom line
What is IVBDX's expense ratio?
IVBDX's expense ratio is 0.56%, or about $56 a year on every $10,000 invested. That is cheaper than 80% of global bond funds we track (median 0.89%). It has no front-end sales load.
Updated Jul 29, 2026
IVBDX fee table
| Net expense ratio | 0.56% |
|---|---|
| Gross expense ratio | 0.77% |
| Management fee | 0.63% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0.14% |
| Fee waiver / reimbursement | -0.21% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Jul 29, 2026
What IVBDX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IVBDX | $57 | $225 | $407 | $935 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.56% expense ratio costs roughly $32,200 in lost growth, versus about $49,800 for the median global bond fund (0.89%).